ANIXA BIOSCIENCES, INC. Inventory, LIFO Reserve, Effect on Income, Net
ANIXA BIOSCIENCES, INC. (ANIX) reported Inventory, LIFO Reserve, Effect on Income, Net of $26.49 thousand for the 9-month period ending 2013-07-31, per its 10-Q/A filed 2013-09-20.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InventoryLIFOReserveEffectOnIncomeNet · last filed 2013-09-20
- ANIXA BIOSCIENCES, INC. inventory, lifo reserve, effect on income, net for the quarter ending 2013-07-31 was $0.00.
- ANIXA BIOSCIENCES, INC. inventory, lifo reserve, effect on income, net for the quarter ending 2013-04-30 was $0.00.
- ANIXA BIOSCIENCES, INC. inventory, lifo reserve, effect on income, net for the quarter ending 2013-01-31 was $26.49K.
| Period end | Inventory, LIFO Reserve, Effect on Income, Net 3 month | Inventory, LIFO Reserve, Effect on Income, Net 6 month | Inventory, LIFO Reserve, Effect on Income, Net 9 month |
|---|---|---|---|
| 2013-07-31 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-09-20 | $0.00 derived: sum of 2 quarters · filed 2013-09-20 | $26.49K 10-Q/A · filed 2013-09-20 |
| 2013-04-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-06-19 | $26.49K 10-Q/A · filed 2013-06-19 | |
| 2013-01-31 | $26.49K 10-Q/A · filed 2013-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |